Cspc Zhongnuo Pharmaceutical (shijiazhuang) Co., Ltd.

This study tested a new injectable drug, SYH2053, in 156 adults with high cholesterol or mixed lipid problems. The goal was to see how well it lowers 'bad' LDL cholesterol compared to a placebo or an active drug. Participants followed a low-fat diet and either took stable cholest…

This study compared a new generic version of paliperidone palmitate injection to the standard brand-name drug in 256 Chinese adults with schizophrenia. The goal was to see if the new version reaches similar levels in the blood, meaning it should work just as well. Participants re…